Gail Gannon, Managing Director, at WaveEdge Capital Speaks at Women in Bio 1/12/2017
On the morning of January 12, 2017, Women In Bio and Bloomberg Intelligence had a half-day event following the conclusion of the JP Morgan conference. The event kicked off with a WIB members breakfast followed by two panel discussions. Our panel discussion featured leaders in the biotech and investment industries, who detailed how federal policy changes in 2017 will shape biotech funding over the next few years. This event was a great chance to reflect on the 2017 JP Morgan conference, mingle with leaders in the biotech funding space, and interact with WIB members from across the country.
Gail Gannon was a panelist in “Early stage investing and fund raising in biotech.”
Click here for more information.